Key result
Biomimetic peroxisome (Mn@LPEV) achieved a 4-fold increase in targeting deep heart tissues in I/R mice compared with control vesicles, reducing acute mortality and protecting heart function.
Why the study?
Heart ischemic injury causes mitochondrial dysfunction, ROS accumulation, DNA damage response, cell cycle arrest, and lactate accumulation associated with acute death.
Does a biomimetic peroxisome (Mn@LPEV) improve heart repair and regeneration in an ischemia/reperfusion mouse model?
Does a biomimetic peroxisome (Mn@LPEV) improve heart repair and regeneration in an ischemia/reperfusion mouse model?
Effect estimate: 4-fold increase
A novel biomimetic peroxisome delivery system effectively targets ischemic myocardium, scavenges ROS and lactate, and promotes heart repair and regeneration in a mouse model of ischemia/reperfusion injury.
May aid metabolic recovery in ischemic myocardium; leaves open clinical translation of biomimetic peroxisomes.
Heart ischemic injury predominately causes mitochondrial dysfunction, leading to the accumulation of ROS and lactate. The ROS-associated DNA damage response (DDR) contributes to myocardial cell cycle arrest and the inhibition of proliferation, while lactate accumulation is often accompanied by a high risk of acute death. In this study, to restore myocardial metabolism and regenerate the heart, we established a biomimetic peroxisome by loading the Mn 3 O 4 nanozyme into mesenchymal stem cell-derived extracellular vesicles (MSC-EV (Mn@EV)). This setup mimics the peroxidases of peroxisome to catalyze ROS, and inhibit DDR. Next, the Mn@EV was immobilized with lactate oxidase (LOX) after encompassed platelet membrane to obtain biomimetic peroxisome (Mn@LPEV). This mimics the substrate-oxidizing function to detoxify lactate and prevent death. Supported by its biomimetic and lactate-response delivery system, our biomimetic peroxisome effectively targeted deep tissues in the hearts of I/R mice, achieving a 4-fold increase in targeting compared with control vesicles. It maintained myocardial redox homeostasis by scavenging ROS and lactate, inhibiting DDR pathway, promoting myocardial regeneration, reducing acute mortality and fibrosis remodeling, accelerating immunomodulation and angiogenesis, and significantly protecting heart function.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) studied Heart ischemic injury (Ischemia/Reperfusion). Biomimetic peroxisome (Mn@LPEV) vs. Control vesicles was evaluated on Targeting deep tissues in the hearts (4-fold increase). Biomimetic peroxisome (Mn@LPEV) achieved a 4-fold increase in targeting deep heart tissues in I/R mice compared with control vesicles, reducing acute mortality and protecting heart function.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: